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ABSTRACT 
BACKGROUND: Ischemic preconditioning (IPC) has well-established cardiac and vascular 
protective effects. Short interventions (1-week) of daily IPC episodes improve conduit and 
microcirculatory function. This study examined whether a longer (8-weeks) and less frequent 
(3 per-week) protocol of repeated IPC improves vascular function. METHODS: Eighteen 
males were randomly allocated to either IPC (22.4±2.3 yrs, 23.7±3.1 kg.m2) or a control 
intervention (26.0±4.8 yrs, 26.4±1.9 kg.m2). Brachial artery endothelial-dependent (FMD), 
forearm cutaneous microvascular function and cardiorespiratory fitness were assessed at 0, 
2 and 8 weeks. RESULTS: A greater improvement in FMD was evident following IPC 
training compared to control at weeks 2 [2.24% (0.40, 4.08); P=0.02] and 8 [1.11% (0.13, 
2.10); P=0.03]. Repeated IPC did not change cutaneous microcirculatory function or fitness. 
CONCLUSIONs: These data indicate that a feasible and practical protocol of regular IPC 
episodes improves endothelial function in healthy individuals within 2 weeks, and these 
effects persist following repeated IPC for 8 weeks.  
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INTRODUCTION 
Ischemic preconditioning (IPC) is characterised by brief episodes of ischemia followed by 
reperfusion (single or multiple bouts) and offers cardiac and vascular protection against 
prolonged ischemia and ischemia reperfusion injury (IRI).1, 2 Recent studies have examined 
daily exposure of IPC episodes as a therapeutic intervention and found enhanced brachial 
artery endothelial function3, skin perfusion3, resistance4 artery function and protection from 
conduit artery induced IRI5. Therefore, daily IPC may potentially be a useful intervention to 
improve vascular function. 
 
Cardiovascular protection from IPC is present for 1-2 h following an IPC episode (early 
phase). Whilst effects diminish after 24 h, they persist for 3-4 days (late phase)6. Given 
these characteristics, application of IPC on a daily basis may not be necessary. Furthermore, 
previous studies have examined relatively short periods of repeated IPC (≥1 week), which 
raises the question whether prolonged exposure to repeated IPC will maintain or further 
improve the effects on the vasculature. Therefore, we examined the impact of regular bouts 
of IPC (3 x per week) for 8-weeks on conduit artery and microcirculatory function in young 
healthy male individuals.  
 
METHODS 
Participants 
Eighteen males, non-smokers, free from cardiovascular disease were recruited. The study 
was approved by the university ethics committee and conformed to the Declaration of 
Helsinki. All participants provided written informed consent. 
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Research Design  
Participants were randomly assigned (computer-generated sequence) to IPC (n=9, 22.4±2.3 
yrs, BMI 23.7±3.1 kg.m2) or control (n=9, no intervention, 26.0±4.8 yrs, BMI 26.4±1.9 kg.m2). 
The intervention-arm was counterbalanced and allocation to the intervention was performed 
prior to measurements. Assessment of, brachial artery function and cutaneous 
microcirculatory function on the arm assigned to the intervention was performed at week 0, 2 
and 8. Participants fasted for 6 h, refrained from alcohol and exercise for 24 h and caffeine 
for 6 h before each visit. 
 
Experimental Measurements  
Following 30-min supine rest, images of the brachial artery using high-resolution ultrasound 
were acquired (Terason, t3000, Aloka, UK). Brachial artery endothelium-dependent 
vasodilation was assessed via flow mediated dilation (FMD). Diameter, flow, and shear 
stress were measured prior to, and following 5 min of forearm cuff inflation7. Analysis was 
performed using custom-designed edge-detection and wall-tracking software by single 
person following completion of the final participant who was blinded to the treatment 
allocation.7, 8  Allometric scaling for baseline diameter was performed in our analysis. 9 
 
Red blood cell flux was measured on the forearm using laser-Doppler flowmetry (Periflux 
5001, Sweden). Skin temperature was controlled with local heating units (Perimed 455, 
Sweden). Mean arterial pressure (MAP) was measured using finger photoplethysmography 
(Finapres Medical Systems, Netherlands). Following 10min of baseline,  heating from 33 to 
42ºC (0.5 ºC per 5 s) occurred and then held at 42ºC for 30 min. Cutaneous vascular 
conductance (CVC) was calculated as flux (mV) divided by MAP (mmHg). 
 
A single observer measured height and body mass. Following a 2-min warm-up, the 
treadmill workload increased with step-wise increments in speed and gradient. VO2peak was 
calculated from expired gas fractions (Oxycon Pro, Jaeger, Germany) as the highest 
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consecutive 15s period of oxygen uptake occurring in the minute before volitional 
exhaustion. Anthropometric and fitness measurements performed at week 0 and 8 only. 
 
IPC Intervention: A cuff around the upper arm was inflated to 220 mmHg for 5 min using a 
rapid inflator to produce an ischemic stimulus, and then deflated to allow reperfusion for 5 
min. This cycle was repeated 4 times per episode. Three episodes per week were 
administered for 8-weeks. Participants were supervised for each IPC episode. 
 
Control Intervention: Normal routine, no alteration of physical activity or dietary habits. 
 
Statistical analysis 
Delta change from week 0 was calculated10 and analysed using linear mixed modelling, with 
week 0 data as a covariate to account for any differences between groups using the 
Statistics Package for Social Sciences for Windows (SPSS Inc. Chicago, IL, USA). Data are 
presented as mean and 95% confidence intervals.   
 
Results 
Two individuals (1 IPC, 1 control) dropped out during the study. Individuals in the IPC-
intervention (n=8) demonstrated 96% compliance. There were negligible differences in the 
change in MAP at week 2 [3 mmHg (-11, 15); P=0.72] and week 8 [1 mmHg (-10, 11); 
P=0.30] between IPC and control. Similarly, fitness [1.38 ml.kg-1.min-1 (-2.67, 5.43); P=0.47] 
and body mass index [0.37 kg.m2 (-1.12, 0.37); P=0.98] did not change with the interventions. 
 
Brachial artery FMD: A significant increase in FMD was evident following IPC at week 2 
[2.24% (0.40, 4.08); P=0.02] and week 8 [1.11% (0.13, 2.10); P=0.03] compared to control. 
The intervention did not impact on brachial artery diameter, time-to-peak diameter and shear 
rate area-under-the-curve.  
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Cutaneous microcirculation: IPC did not significantly affect resting CVC%max at week 2 [1.8% 
(-1.8, 5.4); P=0.30] or week 8 [0.41% (-2.0, 2.8), P=0.72] when compared to control. The 
local heating protocol induced the typical pattern of an initial peak, nadir and a plateau in 
skin flux during all assessments. IPC did not affect CVC%max at the initial peak at week 2 
[P=0.96] or week 8 [P=0.68], the nadir at week 2 [P=0.26] or week 8 [P=0.68] or plateau at 
week 2 [P=0.39] or week 8 [P=0.96].  
 
Discussion 
The novel finding of this study was that 8-weeks of IPC, enhanced brachial artery FMD, 
compared to a control group who received no intervention. Importantly, enhanced FMD was 
evident after only 2-weeks (i.e. 6 IPC sessions) and remained elevated after 8-weeks. 
Although we observed no effect on cutaneous perfusion, our data collectively suggest that a 
protocol of regular IPC is an effective and low-cost tool to improve conduit artery function in 
healthy individuals. 
 
An important difference with previous reports is that we adopted only 3 IPC episodes per 
week compared to daily IPC.3, 4 The design of less frequent repeated IPC, was informed by 
the timing of the late phase of protection, suggesting that daily episodes of IPC may not be 
necessary for optimal benefit.6 Therefore by design, FMD improvements in our study 
coincide with the late phase of protection, which is believed to be induced by de novo 
synthesis of cardioprotective proteins, such as upregulation of the NO-pathway and 
cyclooxygenase-2.11 However, mechanisms of cardioprotection of a single bout of IPC may 
substantially differ from those linked to the effects of repeated IPC.12 Interestingly, 
application of exercise and/or heat exposure interventions of similar frequency and duration 
also improve brachial artery FMD in healthy individuals;13-15 and may cause similar 
adaptations to improve vascular function. In support of this concept, one previous study has 
shown that an acute bout of exercise has preconditioning effects against IRI using an animal 
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model.16 Preconditioning effects of an exercise bout has also been shown previously on 
cardiac function in patients with coronary artery disease.17 
 
Early reports have raised concerns about the application of repeated IPC, suggesting 
repeated protocols may negate vascular protection.18 Nevertheless, we found FMD was 
enhanced after 2-weeks (i.e. 6 IPC episodes) and remained significantly elevated after 8-
weeks, indicating that the protocol of repeated IPC in healthy individuals for 8-weeks does 
not negate initial beneficial vascular adaptations. Whilst it is possible that the impact of IPC 
attenuates over time, this could be explained by structural changes in the vascular bed 
which occur after regular and repeated exposure to a stimulus 8. 
 
We did not observe changes in cutaneous blood flow, which contrasts our previous findings 
with daily IPC3 and reports of enhanced cutaneous blood flow following a single episode of 
IPC.19 Our previous findings could be related reduced blood pressure,3 which was not 
evident in the current study. Alternatively, the stimulus in the current study might not have 
been of sufficient frequency to induce adaption in the cutaneous circulation, such as that 
observed with daily intervention.  
 
Improvements of vascular function is a central feature of various non-pharmacological 
interventions, importantly, increases in vascular function are associated with reductions in 
cardiovascular disease risk. A 1% increase in FMD is associated with a 13% reduction in 
cardiovascular events20. Our data therefore provide clinically meaningful insight, in that 
repeated exposure to episodes of IPC can improve FMD in young healthy individuals. These 
findings support future research to examine the impact of repeated IPC protocols in those 
with a priori vascular dysfunction (e.g. individuals with cardiovascular risk factors). 
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